Michelini, Giorgia http://orcid.org/0000-0002-0887-7582
Kitsune, Viryanaga
Vainieri, Isabella
Hosang, Georgina M.
Brandeis, Daniel
Asherson, Philip
Kuntsi, Jonna http://orcid.org/0000-0002-0113-8162
Funding for this research was provided by:
Economic and Social Research Council (ES/100971X/1)
Medical Research Council (G9817803)
National Institute for Health Research
Article History
Received: 10 October 2017
Accepted: 25 January 2018
First Online: 7 February 2018
Compliance with Ethical Standards
:
: Professor Jonna Kuntsi has given talks at educational events sponsored by Medice; all funds are received by King’s College London and used for studies of ADHD. Prof Philip Asherson has received funding for research by Vifor Pharma, and has given sponsored talks and been an advisor for Shire, Janssen-Cilag, Eli-Lilly, Flynn Pharma and Pfizer, regarding the diagnosis and treatment of ADHD. All funds are received by King’s College London and used for studies of ADHD. Prof Daniel Brandeis serves as an unpaid scientific advisor for an EU-funded Neurofeedback trial unrelated to the present work. The other authors report no conflicts of interest.